These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17208142)

  • 41. [Cystectomy in the treatment of bladder cancer].
    Babjuk M; Hanus T; Safarík L; Dvorácek J; Pavlík I; Soukup V; Pesl M; Szakacsová M; Dusková J
    Cas Lek Cesk; 2007; 146(10):751-7. PubMed ID: 18020006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
    Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004.
    Hellenthal NJ; Ramírez ML; Evans CP; deVere White RW; Koppie TM
    J Urol; 2009 Jun; 181(6):2490-5. PubMed ID: 19371902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
    Merseburger AS; Kuczyk MA
    Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of robot-assisted surgery for bladder cancer.
    Hemal AK
    Curr Opin Urol; 2009 Jan; 19(1):69-75. PubMed ID: 19057220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
    Liang JT; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of stapling devices on radical cystectomy: comparative study between low- and high-volume surgeons.
    Tzortzis V; Gravas S; Mitsogiannis IC; Moutzouris G; Karatzas A; Leventis A; Mpouzalas I; Melekos MD
    Urology; 2008 Feb; 71(2):337-40. PubMed ID: 18308115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
    Fernando SA; Sandler HM
    Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis.
    Haber GP; Crouzet S; Gill IS
    Eur Urol; 2008 Jul; 54(1):54-62. PubMed ID: 18403100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer.
    Coen JJ; Zietman AL; Kaufman DS; Shipley WU
    Urol Oncol; 2007; 25(1):76-84. PubMed ID: 17208144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Stein JP; Penson DF; Wu SD; Skinner DG
    J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
    Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.